MedPage Today (9/19, Monaco) reports, “Brexpiprazole (Rexulti) helped ease agitation in people with Alzheimer’s dementia,” investigators concluded in a 225-patient, 12-week “phase III study,” the findings of which were presented in a poster at Psych Congress 2022. (SOURCE: APA Headlines)